September 06, 2019
Rose
Health Care, The Health Care Blog
No comments
Related Posts:
The Optimistic OncologistBy BISHAL GYAWALI, MD Why conduct post approval studies at all? Atezolizumab previously received accelerated approval in second-line metastatic or advanced urothelial cancer based on response rates from a singl… Read More
Global Risk Report: Davos, Trump and Climate ChangeBy DAVID INTROCASO During the recent World Economic Forum in Davos, Switzerland, President Trump once again noted his objection to the Paris climate accord. In an interview with Piers Morgan, Trump again called it a “ho… Read More
It’s (Still) the Prices, StupidBy SETH HARDY Inefficient markets create price differentials for identical goods. These price differentials frequently occur among markets dominated by oligopolies. Taking advantage of market pricing inefficiencies is known a… Read More
Will Amazon Eat the Market?By PAUL KECKLEY Last Tuesday, a trio of corporate heavy weights announced they were joining forces to fix the U.S. healthcare system. The CEOs of the three—Jeff Bezos of Amazon, Warren Buffet of Berkshire Hathaway, and Jamie … Read More
Sexism in Healthcare ReportingBy NIRAN AL-AGBA, MD NBC should consider re-branding as the “anti-woman” network. Our culture needs to change so women feel valued and respected, comfortable and safe in the workplace, and are provided ample opportunit… Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment